“…Based on the above mechanism, riboflavin mediated UV cross‐linking has been used to stiffen the stromal collagen, thus, retarding progression in the corneal diseases (Chan & Snibson, ; Mazzotta, Baiocchi, Denaro, Tosi, & Caporossi, ; Tomkins & Garzozi, ), with promising results from extensive experimental studies in rabbit (Wollensak, Wilsch, Spoerl, & Seiler, ), porcine, and clinical trial (Ashwin & McDonnell, ). Recently, this technique was applied to enhance other collagenous materials or matrix, such as dentin (Cova et al, ), fibrils (Rich, Odlyha, Cheema, Mudera, & Bozec, ), cell scaffolds (Shahban, Brown, Bozec, & Cheema, ), and tissue engineering material (Kato et al, ).…”